0001415889-24-006685.txt : 20240305
0001415889-24-006685.hdr.sgml : 20240305
20240305163258
ACCESSION NUMBER: 0001415889-24-006685
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YOUNG TODD S.
CENTRAL INDEX KEY: 0001682584
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 24721176
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 825497352
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
form4-03052024_090309.xml
X0508
4
2024-03-01
0001739104
Elanco Animal Health Inc
ELAN
0001682584
YOUNG TODD S.
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
false
true
false
false
SEE REMARKS
0
Common Stock
2024-03-01
4
A
0
43903
0
A
152176
D
Common Stock
2024-03-01
4
F
0
14000
16.03
D
138176
D
Common Stock
2024-03-05
4
G
0
37999
0
D
100177
D
Common Stock
2024-03-05
4
G
0
37999
0
A
152308
I
By Living Trust
Common Stock
2024-03-05
4
G
0
1500
0
D
150808
I
By Living Trust
Common Stock
2024-03-05
4
G
0
1500
0
A
3500
I
As UTMA custodian for daughter
Common Stock
2024-03-05
4
G
0
1500
0
D
149308
I
By Living Trust
Common Stock
2024-03-05
4
G
0
1500
0
A
3500
I
As UTMA custodian for son
Common Stock
6562
I
By IRA
Common Stock
2000
I
By J. G. Young IRA
Employee Stock Option(right to buy)
16.03
2024-03-01
4
A
0
95749
0
A
2034-03-01
Common Stock
95749
95749
D
Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
On March 5, 2024, the reporting person transferred 37,999 directly owned shares to a living trust, of which the insider and his spouse are trustees and beneficiaries.
Reflects a transfer to the reporting person as custodian for daughter under Uniform Gift to Minors Act.
Reflects a transfer to the reporting person as custodian for son under Uniform Gift to Minors Act.
Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
Executive Vice President and Chief Financial Officer
/s/ Amy C. Seidel, as Attorney-in-Fact for Todd S. Young
2024-03-05